Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1980 Feb;132(2):106–110.

Intravenously Given Methylprednisolone in Refractory Asthma

H Alan Krouse, Silverio M Santiago, William B Klaustermeyer
PMCID: PMC1271978  PMID: 7385823

Abstract

A study was designed to compare the time course response of two high-dose methylprednisolone regimens in adult refractory corticosteroid-dependent asthmatics: Group A received 125 mg intravenously every six hours for three days; group B received 125 mg every six hours for ten days. Sixteen patients during 22 hospital stays were randomly assigned to one of the two groups. Forced vital capacity (FVC), forced expired volume in one second (FEV1) and forced expiratory flow between 25 percent and 75 percent of vital capacity (FEF25%-75%) improved significantly over the ten days in both groups (P<.005) in all patients. No differences in baseline two-, four-, seven- or ten-day spirometric values were noted between groups (P>.2).

In most steroid-dependent asthmatic patients, three days' therapy with 125 mg every six hours of methylprednisolone given intravenously resulted in obvious and sustained ventilatory improvement. Close observation with spirometric and clinical evaluation is then necessary to detect the occasional patient in whom relapse will occur and longer periods of high-dose steroid therapy will be needed.

Full text

PDF
106

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARACH A. L., BICKERMAN H. A., BECK G. J. Clinical and physiological studies on the use of metacortandracin in respiratory disease. I. Bronchial asthma. Dis Chest. 1955 May;27(5):515–527. doi: 10.1378/chest.27.5.515. [DOI] [PubMed] [Google Scholar]
  2. BURRAGE W. S., IRWIN J. W. The role of cortisone in the treatment of severe bronchial asthma. N Engl J Med. 1953 Apr 16;248(16):679–682. doi: 10.1056/NEJM195304162481604. [DOI] [PubMed] [Google Scholar]
  3. Britton M. G., Collins J. V., Brown D., Fairhurst N. P., Lambert R. G. High-dose corticosteroids in severe acute asthma. Br Med J. 1976 Jul 10;2(6027):73–74. doi: 10.1136/bmj.2.6027.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CARRYER H. M., KOELSCHE G. A., PRICKMAN L. E., MAYTUM C. K., LAKE C. F., WILLIAMS H. L. Effects of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. Proc Staff Meet Mayo Clin. 1950 Aug 16;25(17):482–486. [PubMed] [Google Scholar]
  5. Cayton R. M., Howard P. Plasma cortisol and the use of hydrocortisone in the treatment of status asthmaticus. Thorax. 1973 Sep;28(5):567–573. doi: 10.1136/thx.28.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collins J. V., Clark T. J., Brown D., Townsend J. The use of corticosteroids in the treatment of acute asthma. Q J Med. 1975 Apr;44(174):259–273. [PubMed] [Google Scholar]
  7. Collins J. V., Clark T. J., Harris P. W., Townsend J. Intravenous corticosteroids in treatment of acute bronchial asthma. Lancet. 1970 Nov 21;2(7682):1047–1049. doi: 10.1016/s0140-6736(70)90283-7. [DOI] [PubMed] [Google Scholar]
  8. Ellul-Micallef R., Fenech F. F. Intravenous prednisolone in chronic bronchial asthma. Thorax. 1975 Jun;30(3):312–315. doi: 10.1136/thx.30.3.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Klaustermeyer W. B., Hale F. C. The physiologic effect of an intravenous glucocorticoid in bronchial asthma. Ann Allergy. 1976 Aug;37(2):80–86. [PubMed] [Google Scholar]
  10. McDougal B. A., Whittier F. C., Cross D. E. Sudden death after bolus steroid therapy for acute rejection. Transplant Proc. 1976 Sep;8(3):493–496. [PubMed] [Google Scholar]
  11. McFadden E. R., Jr, Kiser R., deGroot W. J., Holmes B., Kiker R., Viser G. A controlled study of the effects of single doses of hydrocortisone on the resolution of acute attacks of asthma. Am J Med. 1976 Jan;60(1):52–59. doi: 10.1016/0002-9343(76)90533-7. [DOI] [PubMed] [Google Scholar]
  12. McFadden E. R. The chronicity of acute attacks of asthma--mechanical and therapeutic implications. J Allergy Clin Immunol. 1975 Jul;56(1):18–26. doi: 10.1016/0091-6749(75)90030-5. [DOI] [PubMed] [Google Scholar]
  13. Morris J. F., Koski A., Johnson L. C. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis. 1971 Jan;103(1):57–67. doi: 10.1164/arrd.1971.103.1.57. [DOI] [PubMed] [Google Scholar]
  14. Pierson W. E., Bierman C. W., Kelley V. C. A double-blind trial of corticosteroid therapy in status asthmaticus. Pediatrics. 1974 Sep;54(3):282–288. [PubMed] [Google Scholar]
  15. RANDOLPH T. G., ROLLINS J. P. The effect of cortisone on bronchial asthma. J Allergy. 1950 Jul;21(4):288–295. doi: 10.1016/0021-8707(50)90060-8. [DOI] [PubMed] [Google Scholar]
  16. Rebuck A. S., Read J. Assessment and management of severe asthma. Am J Med. 1971 Dec;51(6):788–798. doi: 10.1016/0002-9343(71)90307-x. [DOI] [PubMed] [Google Scholar]
  17. Schmidt G. B., Bennett E. J., Dalal R. Y. Death precipitated by tracheostomy in a child. JAMA. 1975 Jan 20;231(3):277–278. [PubMed] [Google Scholar]
  18. Stubbs S. S., Morrell R. M. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy. Transplant Proc. 1973 Jun;5(2):1145–1146. [PubMed] [Google Scholar]
  19. VanArsdel P. P., Jr, Paul G. H. Drug therapy in the management of asthma. Ann Intern Med. 1977 Jul;87(1):68–74. doi: 10.7326/0003-4819-87-1-68. [DOI] [PubMed] [Google Scholar]
  20. Webb-Johnson D. C., Andrews J. L., Jr Bronchodilator therapy (second of two parts). N Engl J Med. 1977 Oct 6;297(14):758–764. doi: 10.1056/NEJM197710062971405. [DOI] [PubMed] [Google Scholar]
  21. Woolcock A. J., Read J. Lung volumes in exacerbations of asthma. Am J Med. 1966 Aug;41(2):259–273. doi: 10.1016/0002-9343(66)90021-0. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES